Marqeta Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Marqeta Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cash flows from operating activities: | ||||||||||||||||
| net income | -647,000 | -8,260,000 | -27,118,000 | -28,643,000 | 119,108,000 | -36,060,000 | -40,375,000 | -54,989,000 | -58,797,000 | -68,801,000 | -26,326,000 | -53,168,000 | -44,688,000 | -60,598,000 | -36,807,000 | -45,730,000 |
| adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||
| depreciation and amortization | 6,653,000 | 5,331,000 | 5,519,000 | 4,448,000 | 3,956,000 | 3,537,000 | 3,159,000 | 3,108,000 | 2,494,000 | 1,980,000 | 1,019,000 | 934,000 | 921,000 | 979,000 | 967,000 | 786,000 |
| share-based compensation expense | 27,070,000 | 25,915,000 | 33,304,000 | 35,654,000 | 23,170,000 | 44,434,000 | 45,027,000 | 45,548,000 | 44,165,000 | 45,999,000 | 45,081,000 | 43,509,000 | 35,148,000 | 37,005,000 | 36,767,000 | 38,965,000 |
| executive chairman long-term performance award | 0 | 0 | ||||||||||||||
| non-cash operating leases expense | 486,000 | 535,000 | 739,000 | 759,000 | -416,000 | 674,000 | 657,000 | 639,000 | 624,000 | 607,000 | 592,000 | 578,000 | 563,000 | 548,000 | 536,000 | 521,000 |
| accretion of discount on short-term investments | -216,000 | -396,000 | ||||||||||||||
| other | 534,000 | 364,000 | 1,341,000 | 373,000 | -226,000 | 181,000 | -332,000 | 569,000 | 290,000 | 209,000 | 204,000 | 119,000 | 44,000 | 282,000 | 46,000 | -10,000 |
| changes in operating assets and liabilities: | ||||||||||||||||
| accounts receivable | -8,954,000 | 1,312,000 | -3,917,000 | -593,000 | -2,421,000 | -4,271,000 | -3,448,000 | -1,171,000 | -1,491,000 | 1,554,000 | -2,848,000 | -4,796,000 | 844,000 | 4,223,000 | -5,914,000 | -1,442,000 |
| settlements receivable | -565,000 | 1,795,000 | -4,386,000 | 15,948,000 | 8,746,000 | -6,589,000 | -10,417,000 | -8,990,000 | 745,000 | 6,768,000 | -7,678,000 | 83,000 | -1,340,000 | 2,173,000 | 4,185,000 | -5,853,000 |
| network incentives receivable | -20,145,000 | 1,836,000 | -20,109,000 | -12,499,000 | 20,055,000 | -416,000 | -19,232,000 | 32,488,000 | -7,700,000 | -16,702,000 | -15,598,000 | -13,797,000 | 32,455,000 | -15,322,000 | 9,625,000 | -2,587,000 |
| prepaid expenses and other assets | 6,821,000 | -2,543,000 | -2,733,000 | 717,000 | 1,940,000 | 538,000 | 140,000 | -6,707,000 | 7,264,000 | 7,203,000 | 2,975,000 | 3,386,000 | 6,274,000 | -21,256,000 | -1,653,000 | -6,443,000 |
| accounts payable | 1,890,000 | 1,023,000 | 2,924,000 | -4,687,000 | 1,298,000 | 115,000 | 2,394,000 | -1,111,000 | -3,463,000 | 224,000 | 1,145,000 | 718,000 | -808,000 | -801,000 | -92,000 | 300,000 |
| revenue share payable | -9,775,000 | 16,016,000 | 26,318,000 | -9,344,000 | -13,439,000 | 16,219,000 | 27,162,000 | 20,630,000 | -21,015,000 | 4,674,000 | 26,099,000 | -992,000 | -12,958,000 | 8,866,000 | 32,996,000 | 6,168,000 |
| accrued expenses and other liabilities | 10,514,000 | -31,837,000 | 14,567,000 | 7,029,000 | 9,536,000 | -16,020,000 | 11,652,000 | 15,159,000 | 13,079,000 | -24,907,000 | 9,113,000 | 20,131,000 | 6,950,000 | -13,937,000 | 15,335,000 | 11,299,000 |
| operating lease liabilities | -1,119,000 | -1,104,000 | -1,112,000 | -1,054,000 | -137,000 | -938,000 | -895,000 | -857,000 | -833,000 | -809,000 | -789,000 | -767,000 | -743,000 | -721,000 | -625,000 | -727,000 |
| net cash from operating activities | 12,547,000 | 9,987,000 | 24,755,000 | 7,281,000 | 25,708,000 | 426,000 | 16,522,000 | 41,102,000 | -25,974,000 | -10,546,000 | 14,928,000 | -3,951,000 | 22,816,000 | -46,759,000 | 55,619,000 | -4,460,000 |
| capex | -7,874,000 | -7,325,000 | -4,253,000 | -4,295,000 | -6,166,000 | -6,498,000 | -2,441,000 | -3,147,000 | -3,454,000 | -3,609,000 | -619,000 | -832,000 | -256,000 | -612,000 | -492,000 | -1,155,000 |
| free cash flows | 4,673,000 | 2,662,000 | 20,502,000 | 2,986,000 | 19,542,000 | -6,072,000 | 14,081,000 | 37,955,000 | -29,428,000 | -14,155,000 | 14,309,000 | -4,783,000 | 22,560,000 | -47,371,000 | 55,127,000 | -5,615,000 |
| cash flows from investing activities: | ||||||||||||||||
| purchases of property and equipment | -335,000 | -1,266,000 | -36,000 | -189,000 | -1,002,000 | -1,191,000 | -40,000 | -54,000 | -91,000 | -577,000 | -619,000 | -832,000 | -256,000 | -612,000 | -492,000 | -1,155,000 |
| capitalization of internal-use software | -7,539,000 | -6,059,000 | -4,217,000 | -4,106,000 | -5,164,000 | -5,307,000 | -2,401,000 | -3,093,000 | -3,363,000 | -3,032,000 | ||||||
| maturities of short-term investments | 68,732,000 | 22,186,000 | 38,000,000 | 14,000,000 | 0 | 40,000,000 | 64,500,000 | 141,034,000 | ||||||||
| net cash from investing activities | 60,858,000 | 14,861,000 | 33,747,000 | 9,705,000 | -6,166,000 | 33,502,000 | 81,912,000 | 79,129,000 | -24,195,000 | -98,330,000 | 27,778,000 | 1,907,000 | -133,000 | -834,000 | -66,469,000 | -305,599,000 |
| cash flows from financing activities: | ||||||||||||||||
| proceeds from exercise of stock options, including early exercised stock options, net of repurchase of early exercised unvested options | 136,000 | 1,444,000 | 82,000 | 13,000 | 59,000 | 49,000 | 1,208,000 | 1,782,000 | 1,283,000 | 1,016,000 | 3,516,000 | 2,326,000 | 1,436,000 | 1,971,000 | ||
| proceeds from shares issued in connection with employee stock purchase plan | 1,086,000 | 0 | 1,291,000 | 0 | 1,987,000 | 0 | ||||||||||
| taxes paid related to net share settlement of restricted stock units | -8,786,000 | -7,101,000 | -6,364,000 | -8,756,000 | -9,370,000 | -10,917,000 | -8,109,000 | -8,483,000 | -6,324,000 | -3,746,000 | -3,786,000 | -2,996,000 | -3,878,000 | -4,702,000 | -5,104,000 | -8,175,000 |
| repurchase of common stock | -163,923,000 | -111,310,000 | -16,707,000 | -46,556,000 | -57,487,000 | -33,675,000 | -58,901,000 | -64,446,000 | -45,247,000 | -21,826,000 | -65,434,000 | |||||
| net cash from financing activities | -171,579,000 | -116,967,000 | -21,903,000 | -55,299,000 | -65,169,000 | -44,543,000 | -64,511,000 | -124,214,000 | -48,513,000 | -24,556,000 | -63,717,000 | -13,372,000 | 333,000 | -2,731,000 | -1,789,000 | -9,008,000 |
| net decrease in cash, cash equivalents, and restricted cash | -98,174,000 | -92,119,000 | -38,313,000 | -45,627,000 | -10,615,000 | -3,983,000 | -98,682,000 | -133,432,000 | ||||||||
| cash, cash equivalents, and restricted cash- beginning of period | 0 | 931,516,000 | 0 | 0 | 989,472,000 | 0 | 0 | 1,191,646,000 | 0 | 0 | 1,255,381,000 | 0 | 0 | |||
| cash, cash equivalents, and restricted cash - end of period | -98,174,000 | 839,397,000 | 36,599,000 | -38,313,000 | -45,627,000 | 978,857,000 | 33,923,000 | -3,983,000 | -98,682,000 | 1,058,214,000 | -21,011,000 | -15,416,000 | 23,016,000 | 1,205,057,000 | -12,639,000 | -319,067,000 |
| non-cash postcombination compensation expense | 0 | 0 | 0 | 32,430,000 | ||||||||||||
| amortization of premium on short-term investments | ||||||||||||||||
| gain on sale of equity method investment | ||||||||||||||||
| impairment of other financial instruments | 0 | 0 | 0 | 11,616,000 | ||||||||||||
| business combination, net of cash acquired | -147,000 | -3,716,000 | 0 | -131,914,000 | ||||||||||||
| purchase of patents | ||||||||||||||||
| purchases of short-term investments | 80,000,000 | -692,882,000 | ||||||||||||||
| sales of short-term investments | ||||||||||||||||
| realized gain on investments | ||||||||||||||||
| sale of equity method investment | ||||||||||||||||
| payment on acquisition-related contingent consideration | ||||||||||||||||
| decrease in cash, cash equivalents, and restricted cash | ||||||||||||||||
| cash, cash equivalents, and restricted cash - beginning of period | ||||||||||||||||
| amortization of premium (accretion of discount) on short-term investments | -827,000 | -845,000 | -978,000 | -3,214,000 | ||||||||||||
| sales of marketable securities | ||||||||||||||||
| realized gain/loss on investments | -21,000 | |||||||||||||||
| purchase of equity method investment and purchase option | ||||||||||||||||
| proceeds from initial public offering, net of underwriters’ discounts and commissions | 0 | 0 | ||||||||||||||
| payment of contingent consideration | ||||||||||||||||
| proceeds from exercise of warrants | 0 | |||||||||||||||
| payment of deferred offering costs | -1,626,000 | -1,153,000 | ||||||||||||||
| increase in cash, cash equivalents, and restricted cash | ||||||||||||||||
| purchases of patents | ||||||||||||||||
| amortization of premium (accretion of discount) on marketable securities | -975,000 | |||||||||||||||
| purchases of marketable securities | -70,807,000 | -48,835,000 | -8,661,000 | -2,977,000 | -10,022,000 | -80,177,000 | -361,944,000 | |||||||||
| maturities of marketable securities | 108,000,000 | 52,500,000 | 12,000,000 | 3,100,000 | 9,800,000 | 34,200,000 | 57,500,000 | |||||||||
| amortization of premium on marketable securities | -172,000 | 111,000 | 154,000 | 184,000 | 258,000 | |||||||||||
| proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | ||||||||||||||||
| net increase in cash, cash equivalents, and restricted cash | -15,416,000 | 23,016,000 | -50,324,000 | -12,639,000 | -319,067,000 | |||||||||||
| benefit from doubtful accounts | 65,000 | 35,000 | ||||||||||||||
| payment of bank loan and related fees | ||||||||||||||||
| proceeds from exercise of stock options, including early exercised stock options | 301,000 | |||||||||||||||
| repurchase of early exercised unvested options | -41,000 |
We provide you with 20 years of cash flow statements for Marqeta stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Marqeta stock. Explore the full financial landscape of Marqeta stock with our expertly curated income statements.
The information provided in this report about Marqeta stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.